HUP0004561A2 - Dihidrobenzofuránok és az ezeket tartalmazó gyógyszerkészítmények - Google Patents
Dihidrobenzofuránok és az ezeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0004561A2 HUP0004561A2 HU0004561A HUP0004561A HUP0004561A2 HU P0004561 A2 HUP0004561 A2 HU P0004561A2 HU 0004561 A HU0004561 A HU 0004561A HU P0004561 A HUP0004561 A HU P0004561A HU P0004561 A2 HUP0004561 A2 HU P0004561A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- alkyl
- bronchitis
- cycloalkyl
- mono
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- -1 nitro- Chemical class 0.000 abstract 15
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 206010006451 bronchitis Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000004076 pyridyl group Chemical group 0.000 abstract 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 125000005390 cinnolyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 abstract 1
- 125000000332 coumarinyl group Chemical group O1C(=O)C(=CC2=CC=CC=C12)* 0.000 abstract 1
- 125000004981 cycloalkylmethyl group Chemical group 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 125000004473 dialkylaminocarbonyl group Chemical group 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002883 imidazolyl group Chemical group 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 125000000956 methoxy group Chemical class [H]C([H])([H])O* 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000002971 oxazolyl group Chemical group 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000005592 polycycloalkyl group Chemical group 0.000 abstract 1
- 125000003226 pyrazolyl group Chemical group 0.000 abstract 1
- 125000000168 pyrrolyl group Chemical group 0.000 abstract 1
- 125000005493 quinolyl group Chemical group 0.000 abstract 1
- 125000003003 spiro group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 229940124549 vasodilator Drugs 0.000 abstract 1
- 239000003071 vasodilator agent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Az (I) általános képletű új vegyületek[mely képletben R1 jelentésealkoxi-, cikloalkoxi-, cikloalkil-metoxi- vagy fluorral helyettesítettalkoxicsoport; R2 jelentése alkilcsoport; és R3 jelentése hidrogénatomvagy alkilcsoport; vagy R2 és R3 együtt a két szénatommal együtt,amelyekhez kapcsolódnak, spirokapcsolódású, adott esetben oxigén- vagykénatommal megszakított 5, 6 vagy 7 tagú szénhidrogéngyűrűt képeznek;Het jelentése (a), (b) vagy (c) általános képletű heterociklus, aholR4 jelentése R5, -CmH2mR6 vagy -CpH2p-Y-Ar csoport; R5 jelentésehidrogénatom, alkil-, cikloalkil-, cikloalkil-metil-, policikloalkil-,helyettesítetlen fenil- vagy piridilcsoport, helyettesítettfenilcsoport; R6 jelentése hidroxilcsoport, halogénatom, nitro-,ciano-, karboxil-, alkoxi-karbonil-, amino-, mono- vagy dialkil-amino-, amino-karbonil- vagy mono- vagy dialkil-amino-karbonil-csoport; Y jelentése -O-, -S- vagy kovalens kötés; Ar jelentésehelyettesítetlen fenil-, naftil-, piridil-, pirazinil-, piridazinil-,pirimidinil-, kinazolinil-, kinoxalinil-, cinnolil-, izokinolil-,kinolil-, purinil-, benzimidazolil-, benzotriazolil-, benzoxazolil-,kumarinil-, imidazolil-, pirazolil-, oxazolil- vagy pirrolilcsoportvagy helyettesített fenilcsoport; m értéke 1-4; p értéke 1-4] hatékonyhörgúti gyógyászati hatóanyagok. A vegyületek PDE-inhibitorok, melyekpéldául hörgúti gyógyszerként, értágítóként vagy gyulladásosbetegségek gyógyítására használhatók. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97122039 | 1997-12-15 | ||
PCT/EP1998/008054 WO1999031090A1 (en) | 1997-12-15 | 1998-12-10 | Dihydrobenzofurans |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP0004561A2 true HUP0004561A2 (hu) | 2002-03-28 |
HUP0004561A3 HUP0004561A3 (en) | 2002-04-29 |
HU225114B1 HU225114B1 (en) | 2006-06-28 |
Family
ID=8227798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0004561A HU225114B1 (en) | 1997-12-15 | 1998-12-10 | Dihydrobenzofurans, pharmaceutical compositions containing them and use thereof |
Country Status (17)
Country | Link |
---|---|
US (1) | US6380196B1 (hu) |
EP (1) | EP1042319B1 (hu) |
JP (1) | JP2002508368A (hu) |
AT (1) | ATE258930T1 (hu) |
AU (1) | AU753576B2 (hu) |
CA (1) | CA2314111A1 (hu) |
CZ (1) | CZ299304B6 (hu) |
DE (1) | DE69821530T2 (hu) |
DK (1) | DK1042319T3 (hu) |
EE (1) | EE04312B1 (hu) |
ES (1) | ES2216349T3 (hu) |
HU (1) | HU225114B1 (hu) |
IL (1) | IL136359A (hu) |
PL (1) | PL191236B1 (hu) |
PT (1) | PT1042319E (hu) |
SI (1) | SI1042319T1 (hu) |
WO (1) | WO1999031090A1 (hu) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1212089E (pt) | 1999-08-21 | 2006-08-31 | Altana Pharma Ag | Combinacao sinergica de roflumilast e salmeterol |
WO2001019818A1 (en) * | 1999-09-14 | 2001-03-22 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phthalazinone derivatives as pd3/4 inhibitors |
IL148807A0 (en) | 1999-10-25 | 2002-09-12 | Byk Gulden Lomberg Chem Fab | Tetrahydrothiopyran derivatives and pharmaceutical compositions containing the same |
ATE374189T1 (de) | 1999-10-25 | 2007-10-15 | Nycomed Gmbh | Phthalazinon-derivate als pde 4 hemmer |
PL358057A1 (en) | 2000-06-05 | 2004-08-09 | Altana Pharma Ag | Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors |
EE05386B1 (et) * | 2001-02-15 | 2011-02-15 | ALTANA�Pharma�AG | Ftalasinoon-piperidinoderivaadid,ÁnendeÁkasutamineÁjaÁravim |
EP1385838A1 (en) | 2001-04-25 | 2004-02-04 | ALTANA Pharma AG | Piperazino-derivatives and their use as pde4 inhibitor |
CA2445233A1 (en) | 2001-04-25 | 2002-10-31 | Altana Pharma Ag | Phthalazinones derivatives useful as pde4/7 inhibitors |
CN1646118A (zh) * | 2002-03-29 | 2005-07-27 | 中外制药株式会社 | 预防或治疗呼吸系统疾病的药物组合物 |
US20060167001A1 (en) * | 2002-08-10 | 2006-07-27 | Sterk Jan G | Pyridazinone-derivatives as pde4 inhibitors |
WO2004018457A1 (en) * | 2002-08-10 | 2004-03-04 | Altana Pharma Ag | Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors |
WO2004018449A1 (en) * | 2002-08-10 | 2004-03-04 | Altana Pharma Ag | Piperidine-derivatives as pde4 inhibitors |
WO2004018450A1 (en) * | 2002-08-10 | 2004-03-04 | Altana Pharma Ag | Piperidine-n-oxide-derivatives |
JP4778449B2 (ja) * | 2004-02-04 | 2011-09-21 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | Pde4インヒビターとしての2−(ピペリジン−4−イル)−4,5−ジヒドロ−2h−ピリダジン−3−オン誘導体 |
EP1716123A1 (en) * | 2004-02-04 | 2006-11-02 | Altana Pharma AG | Pyridazinone derivatives and their use as pde4 inhibitors |
JP4890439B2 (ja) * | 2005-03-07 | 2012-03-07 | 杏林製薬株式会社 | ピラゾロピリジン−4−イルピリダジノン誘導体とその付加塩及びそれらを有効成分とするpde阻害剤 |
WO2007058392A1 (ja) * | 2005-11-21 | 2007-05-24 | Japan Tobacco Inc. | ヘテロ環化合物およびその医薬用途 |
US20150119399A1 (en) | 2012-01-10 | 2015-04-30 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4721784A (en) * | 1986-12-22 | 1988-01-26 | Ortho Pharmaceutical Corporation | 6-benzoxazinyl-2,3,4,5-tetrahydropyridazin-3-ones |
JPH04504576A (ja) * | 1989-04-17 | 1992-08-13 | ビイク グルデン ロンベルク―ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規アリールピリダジン、その製造、使用およびこれを含有する医薬品 |
JP3120857B2 (ja) | 1990-02-19 | 2000-12-25 | 中外製薬株式会社 | 新規な縮合複素環化合物とこれを用いた抗喘息剤 |
ATE168101T1 (de) * | 1990-10-16 | 1998-07-15 | Byk Gulden Lomberg Chem Fab | Arylpyridazinone |
US5449676A (en) * | 1991-04-26 | 1995-09-12 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Pyridazines |
JPH06508842A (ja) * | 1991-07-05 | 1994-10-06 | ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | 置換ピリダジンの皮膚病に対する使用 |
DK0612321T3 (da) | 1991-10-09 | 1999-12-13 | Syntex Inc | Pyridopyridazinon- og pyridazinthionforbindelser med PDE IV inhiberende aktivitet |
DE4230755A1 (de) * | 1992-09-14 | 1994-03-17 | Schering Ag | Verwendung von PDE-Inhibitoren bei der Behandlung von Nieren- und Ureter-Erkrankungen |
DE69332762T2 (de) | 1992-12-02 | 2003-08-14 | Pfizer Inc., New York | Cathecoldiether als selektive pde iv hemmungsmittel |
US5476834A (en) * | 1993-03-17 | 1995-12-19 | Sumitomo Chemical Company, Limited | Dihydrobenzofuran derivatives, their production and use |
MX9700557A (es) * | 1994-07-22 | 1997-12-31 | Byk Gulden Lomberg Chem Fab | Dihidrobenzofuranos. |
HU219864B (hu) * | 1994-08-09 | 2001-08-28 | Eisai Co., Ltd. | cGMP-PDE inhibitor kondenzált piridazinszármazékok és alkalmazásuk |
DE19533975A1 (de) * | 1995-09-14 | 1997-03-20 | Merck Patent Gmbh | Arylalkyl-diazinone |
US5821250A (en) * | 1996-02-01 | 1998-10-13 | The Procter & Gamble Company | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
-
1998
- 1998-12-10 AU AU22701/99A patent/AU753576B2/en not_active Ceased
- 1998-12-10 WO PCT/EP1998/008054 patent/WO1999031090A1/en active IP Right Grant
- 1998-12-10 PL PL341239A patent/PL191236B1/pl unknown
- 1998-12-10 EE EEP200000335A patent/EE04312B1/xx not_active IP Right Cessation
- 1998-12-10 DE DE69821530T patent/DE69821530T2/de not_active Expired - Fee Related
- 1998-12-10 EP EP98966288A patent/EP1042319B1/en not_active Expired - Lifetime
- 1998-12-10 US US09/554,088 patent/US6380196B1/en not_active Expired - Fee Related
- 1998-12-10 ES ES98966288T patent/ES2216349T3/es not_active Expired - Lifetime
- 1998-12-10 SI SI9830628T patent/SI1042319T1/xx unknown
- 1998-12-10 IL IL13635998A patent/IL136359A/xx not_active IP Right Cessation
- 1998-12-10 PT PT98966288T patent/PT1042319E/pt unknown
- 1998-12-10 CZ CZ20002218A patent/CZ299304B6/cs not_active IP Right Cessation
- 1998-12-10 JP JP2000539014A patent/JP2002508368A/ja not_active Withdrawn
- 1998-12-10 HU HU0004561A patent/HU225114B1/hu not_active IP Right Cessation
- 1998-12-10 CA CA002314111A patent/CA2314111A1/en not_active Abandoned
- 1998-12-10 AT AT98966288T patent/ATE258930T1/de not_active IP Right Cessation
- 1998-12-10 DK DK98966288T patent/DK1042319T3/da active
Also Published As
Publication number | Publication date |
---|---|
PT1042319E (pt) | 2004-06-30 |
US6380196B1 (en) | 2002-04-30 |
EE200000335A (et) | 2001-10-15 |
CZ20002218A3 (cs) | 2000-11-15 |
CA2314111A1 (en) | 1999-06-24 |
AU753576B2 (en) | 2002-10-24 |
EP1042319A1 (en) | 2000-10-11 |
DE69821530D1 (de) | 2004-03-11 |
PL191236B1 (pl) | 2006-04-28 |
EE04312B1 (et) | 2004-06-15 |
DE69821530T2 (de) | 2004-12-23 |
AU2270199A (en) | 1999-07-05 |
ATE258930T1 (de) | 2004-02-15 |
PL341239A1 (en) | 2001-03-26 |
SI1042319T1 (en) | 2004-08-31 |
HUP0004561A3 (en) | 2002-04-29 |
IL136359A0 (en) | 2001-06-14 |
WO1999031090A1 (en) | 1999-06-24 |
DK1042319T3 (da) | 2004-06-01 |
JP2002508368A (ja) | 2002-03-19 |
EP1042319B1 (en) | 2004-02-04 |
ES2216349T3 (es) | 2004-10-16 |
IL136359A (en) | 2003-03-12 |
HU225114B1 (en) | 2006-06-28 |
CZ299304B6 (cs) | 2008-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0004561A2 (hu) | Dihidrobenzofuránok és az ezeket tartalmazó gyógyszerkészítmények | |
EA200000731A1 (ru) | Альфа-аминоамидные производные, полезные в качестве анальгетических агентов | |
DE60005504D1 (de) | Chinolinderivate als mek enzym-inhibitoren | |
ES8505659A1 (es) | Un procedimiento para la preparacion de inhibidores biciclicos de la tromboxano sintetasa. | |
GB1477114A (en) | 1,4-dihydropyridinecarboxylic acid aralkyl esters processes for their preparation and their use as medicaments | |
HUP9902034A2 (hu) | Szukcinimid- és maleimid citokin inhibitorvegyületek | |
HUP0004529A2 (hu) | VLA-4 által mediált leukocita adhéziót gátló szulfonilezett dipeptid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint alkalmazásuk | |
NO155243C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater. | |
CA2304713A1 (en) | Biphenyl-5-alkanoic acid derivatives and use thereof | |
WO2003039451A3 (en) | Thiazole pyridazinones as adenosine antagonists | |
IE43731L (en) | Triazolyl and imidazolyl derivatives | |
YU40798A (en) | Benzopyran derivatives having leukotriene-antagonistic action | |
NO163855C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arylcyklobutylalkylaminer. | |
RU1836372C (ru) | Способ получени имидазопиридазинов | |
ATE67193T1 (de) | 6-phenyl-pyridazin-verbindungen. | |
IE47212B1 (en) | Dihydropyridine derivatives,process for their production and pharmaceutical compositions containing them | |
FR2725719B1 (fr) | Diazepino-indoles inhibiteurs de phosphodiesterases iv | |
GB1389504A (en) | 2-amino-1,4-dihydropyridines their production and their medicinal use | |
GB1336318A (en) | Derivatives of 7-aminocephalosporanic acid | |
IT1201454B (it) | 1,4-diidropiridine-2-sostituite | |
PT1265891E (pt) | Novos derivados heterociclicos ou benzenicos do acido lipoico sua preparacao e sua aplicacao a titulo de medicamentos | |
HUP9802348A2 (hu) | 2-Fenil-3-aroil-benzotiofének alkalmazása plazminogén aktivátor inhibitor-1 gátló hatású gyógyszerkészítmények előállítására | |
HUP0002826A2 (hu) | 6-Azauracil-származékok, eljárás előállításukra, alkalmazásuk gyulladások elleni gyógyszer előállítására és az ilyen kompozíciók | |
ES8201977A1 (es) | Procedimiento de preparacion de aminoalcoxipirazoles | |
ES385437A1 (es) | Metodo para la preparacion de nuevos derivados de acido pe-nicilanico. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB9A | Succession in title |
Owner name: ALTANA PHARMA AG, DE Free format text: FORMER OWNER(S): BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH., DE |
|
MM4A | Lapse of definitive patent protection due to non-payment of fees |